Literature DB >> 3149490

Characteristics of tuberculosis in HIV-infected patients: a case-control study.

E Soriano1, J Mallolas, J M Gatell, X Latorre, J M Miró, M Pecchiar, J Mensa, A Trilla, A Moreno.   

Abstract

To test the hypothesis that HIV infection can modify the clinical characteristics of tuberculosis, 65 consecutive cases of tuberculosis in HIV-seropositive patients diagnosed in Barcelona (Spain) were compared with 65 HIV-seronegative controls matched for age and sex. Thirty of the 65 cases were accepted as AIDS cases (August 1987 Centers for Disease Control criteria) only because of the tuberculosis. Among the cases 54 (83%) were parenteral drug addicts and 88% were males. The tuberculosis was pulmonary or pleural in 62 controls (96%) but in only 25 cases (39%; P less than 0.0001). Lymph nodes were involved in 25 cases (39%) and in none of the controls (P less than 0.0001). Disseminated forms of tuberculosis were present in seven cases (11%) and in no controls (P less than 0.007). Bone, joints and central nervous system involvement were also significantly (P less than 0.05) more frequent in cases. The treatment (isoniazid and rifampin for 6 months plus ethambutol and pyrazinamide during the first 2 months) was always effective. One relapse was detected after a median follow-up of 55 months in cases and none in controls after a median follow-up of 43 months. Twenty-five cases (39%) and 14 controls (22%) developed mild or severe side effects related to the treatment (P less than 0.004). In conclusion, most of the HIV-infected patients with tuberculosis were drug addicts with extrapulmonary or disseminated forms. A short course of treatment (6 or 9 months) may be enough but side effects were frequent.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3149490     DOI: 10.1097/00002030-198812000-00003

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

1.  Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research Collaboration.

Authors:  J L Johnson; A Okwera; P Nsubuga; J G Nakibali; C C Whalen; D Hom; M D Cave; Z H Yang; R D Mugerwa; J J Ellner
Journal:  Int J Tuberc Lung Dis       Date:  2000-11       Impact factor: 2.373

Review 2.  Sexually transmitted hepatitis: a review.

Authors:  R J Gilson
Journal:  Genitourin Med       Date:  1992-04

3.  Transcarinal needle aspiration in the diagnosis of mediastinal adenitis in a patient infected with the human immunodeficiency virus.

Authors:  G Julià Serdà; F Rodriguez de Castro; J M Fernandez Sánchez-Alarcos; J Caminero Luna; F Diaz López; P Cabrera Navarro
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

4.  Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas.

Authors:  F Lozano; J Torre-Cisneros; A Bascuñana; J Polo; P Viciana; M A García-Ordóñez; J Hernández-Quero; M Márquez; A Vergara; F Díez; E Pujol; M Torres-Tortosa; J Pasquau; J J Hernández-Burruezo; I Suárez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-09       Impact factor: 3.267

5.  Pretreatment and posttreatment radiography in patients with pulmonary tuberculosis with and without human immunodeficiency virus infection.

Authors:  Wirana Angthong; Chayanin Angthong; Vithya Varavithya
Journal:  Jpn J Radiol       Date:  2011-09-17       Impact factor: 2.374

6.  Idiopathic CD4+ T-lymphocytopenia in two patients.

Authors:  M Ostrowski; I E Salit; W L Gold; D Sutton; M L Montpetit; D Lepine; T Salas
Journal:  CMAJ       Date:  1993-12-01       Impact factor: 8.262

Review 7.  Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries.

Authors:  P P Nunn; A M Elliott; K P McAdam
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

8.  Intestinal tuberculosis in AIDS.

Authors:  N Bargalló; C Nicolau; P Luburich; C Ayuso; C Cardenal; F Gimeno
Journal:  Gastrointest Radiol       Date:  1992

9.  Impact of HIV on tuberculosis in Zambia: a cross sectional study.

Authors:  A M Elliott; N Luo; G Tembo; B Halwiindi; G Steenbergen; L Machiels; J Pobee; P Nunn; R J Hayes; K P McAdam
Journal:  BMJ       Date:  1990-09-01

10.  Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis.

Authors:  Jose M Miro; Christian Manzardo; Cristina Mussini; Margaret Johnson; Antonella d'Arminio Monforte; Andrea Antinori; M John Gill; Laura Sighinolfi; Caterina Uberti-Foppa; Vanni Borghi; Caroline Sabin
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.